Product NDC: | 0078-0509 |
Proprietary Name: | Tegretol |
Non Proprietary Name: | carbamazepine |
Active Ingredient(s): | 200 mg/1 & nbsp; carbamazepine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0078-0509 |
Labeler Name: | Novartis Pharmaceuticals Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA016608 |
Marketing Category: | NDA |
Start Marketing Date: | 19680311 |
Package NDC: | 0078-0509-05 |
Package Description: | 100 TABLET in 1 BOTTLE (0078-0509-05) |
NDC Code | 0078-0509-05 |
Proprietary Name | Tegretol |
Package Description | 100 TABLET in 1 BOTTLE (0078-0509-05) |
Product NDC | 0078-0509 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | carbamazepine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19680311 |
Marketing Category Name | NDA |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | CARBAMAZEPINE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |